在小鼠模型中用[18F]PARPi与氨基酸PET鉴别放射性损伤与复发肿瘤
研究利用胶质母细胞瘤和放射性坏死小鼠模型,测试PARP靶向[18F]PARPi PET能否鉴别放射性损伤与肿瘤。结果显示放射性坏死病灶对[18F]PARPi摄取与对侧相似(病灶/对侧%IA/ccmax比值1.02±0.26),而[18F]FET-PET清晰勾勒强化区(比值2.12±0.16);U251移植瘤中PARPi-PET显像优于FET-PET,病灶/对侧最大活性比更高(p=0.034)。结论认为放射性坏死小鼠模型不显示[18F]PARPi摄取,[18F]PARPi-PET在单次静态显像中即可鉴别复发肿瘤与放射性损伤。
要点
- 放射性坏死小鼠病灶[18F]PARPi摄取与对侧相似(比值1.02±0.26),无摄取增高。
- 同一模型[18F]FET-PET清晰勾勒强化区(病灶/对侧比值2.12±0.16)。
- U251移植瘤中[18F]PARPi-PET显像优于FET-PET,最大活性比更高(p=0.034)。
核心结论
- 放射性坏死小鼠模型不显示[18F]PARPi摄取,[18F]PARPi-PET在鉴别放射性损伤与脑肿瘤方面优于[18F]FET-PET。
- [18F]PARPi-PET可在单次静态显像中鉴别复发肿瘤与放射性损伤,可能有助于解决神经肿瘤学中的常见困境。
研究设计与样本
- 研究使用胶质母细胞瘤和放射性坏死两种小鼠模型,测试PARP靶向[18F]PARPi PET显像。
主要发现
- 实验性放射性坏死小鼠中,[18F]PARPi-PET病灶摄取与对侧相似,病灶/对侧%IA/ccmax比值为1.02±0.26。
- 同一放射性坏死模型中,[18F]FET-PET清晰勾勒MR上的对比增强区域,病灶/对侧%IA/ccmax比值为2.12±0.16。
- 颅内U251移植瘤小鼠中,PARPi-PET肿瘤显像优于FET-PET,病灶/对侧最大活性比更高(p=0.034)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation injury can be indistinguishable from recurrent tumor on standard imaging. Current protocols for this differential diagnosis require one or more follow-up imaging studies, long dynamic acquisitions, or complex image post-processing; despite much research, the inability to confidently distinguish between these two entities continues to pose a significant dilemma for the treating clinician. Using mouse models of both glioblastoma and radiation necrosis, we tested the potential of poly(ADP-ribose) polymerase (PARP)-targeted PET imaging with [18F]PARPi to better discriminate radiation injury from tumor. RESULTS: In mice with experimental radiation necrosis, lesion uptake on [18F]PARPi-PET was similar to contralateral uptake (1.02 ± 0.26 lesion/contralateral %IA/ccmax ratio), while [18F]FET-PET clearly delineated the contrast-enhancing region on MR (2.12 ± 0.16 lesion/contralateral %IA/ccmax ratio). In mice with focal intracranial U251 xenografts, tumor visualization on PARPi-PET was superior to FET-PET, and lesion-to-contralateral activity ratios (max/max, p = 0.034) were higher on PARPi-PET than on FET-PET. CONCLUSIONS: A murine model of radiation necrosis does not demonstrate [18F]PARPi avidity, and [18F]PARPi-PET is better than [18F]FET-PET in distinguishing radiation injury from brain tumor. [18F]PARPi-PET can be used for discrimination between recurrent tumor and radiation injury within a single, static imaging session, which may be of value to resolve a common dilemma in neuro-oncology.
引用
- Donabedian PL, Kossatz S, Engelbach JA, et al. Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models. EJNMMI Res. 2018. PMID: 29974335. doi:10.1186/s13550-018-0399-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。